Investigating the effect of antioxidant treatment on the protective effect of preconditioning in anesthetized rabbits

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 6, 2011, Pages 609-616

  Andreadou, Ioanna ^a   Iliodromitis, Efstathios K ^a   Souridis, Vassilios ^a   Prokovas, Eftihios ^a   Kostidis, Sarantos ^a   Zoga, Anastasia ^a   Dagres, Nikolaos ^a   Tsantili Kakoulidou, Anna ^a   Kremastinos, Dimitrios Th ^a   Mikros, Emmanuel ^a   Anastasiou Nana, Maria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

metabonomics; N 2 mercaptopropionyl glycine; oxidative stress; preconditioning; reperfusion

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; CARDIAC AGENT; GLUTATHIONE; MALONALDEHYDE; N 2 MERCAPTOPROPIONYL GLYCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; REPERFUSION;

ANIMALS; ANTIOXIDANTS; GLUTATHIONE; INFUSIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPID PEROXIDATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RABBITS; TIME FACTORS; TIOPRONIN; TYROSINE;

EID: 83155180521     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31822fc783     Document Type: Article

References (43)

1. Murry CE, Jenings RB, Reiner KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemia myocardium. Circulation. 1986;74: 1124-1136. (Pubitemid 17174962)
2. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contributes to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol. 1997;29:207-216. (Pubitemid 27129144)
3. Hausenloy DJ, Yellon DM, Mani-Babu S, et al. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol. 2004;287:H841-H849. (Pubitemid 38955321)
4. Skyschally A, Schulz R, Gres P, et al. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid.Am J Physiol Heart Circ Physiol. 2003;284:H698-H703. (Pubitemid 36142899)
5. Tsovolas K, Iliodromitis EK, Andreadou I, et al. Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits.Pharmacol Res. 2008;57:283-289.
6. Andreadou I, Iliodromitis E, Mikros E, et al. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med. 2004; 37:500-510. (Pubitemid 38901082)
7. Andreadou I, Iliodromitis EK, Tsovolas K, et al. Acute administration of vitamin E triggers preconditioning via KATP channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med. 2006;41: 1092-1099. (Pubitemid 44348870)
8. Pain T, Yang XM, Critz SD, et al. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;87:460-466.
9. Liu Y, Yang XM, Iliodromitis EK, et al. Redox signalling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res Cardiol. 2008;103:54-59. (Pubitemid 50002795)
10. Dost T, Cohen MV, Downey JM. Redox signalling triggers protection during the reperfusion rather than the ischemic phase of preconditioning. Basic Res Cardiol. 2008;103:378-384.
11. Horowitz LD, Fennessey PV, Shikes RH, et al. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation. 1994;89:1792-1801. (Pubitemid 24114259)
12. Mitsos SE, Fantone JC, Gallagher KP, et al. Canine myocardial reperfusion injury protection by a free radical scavenger, N-2-mercaptopropionyl glycine. J Cardiovasc Pharmacol. 1986;8:978-988.
13. Lindon JC, Holmes E, Nicholson JK. Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res. 2006;23:1075-1088. (Pubitemid 43946133)
14. Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell. 2008;134:714-717.
15. Iliodromitis EK, Zoga A, Vrettou A, et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis. 2006;188:356-362. (Pubitemid 44313925)
16. Meiboom S, Gill D. Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum. 1959;29:688-691.
17. Aue WP, Karham J, Ernst RR. Homonuclear broad band decoupling and two-dimensional J-resolved NMR spectroscopy. J Chem Phys. 1976;64: 4226-4227.
18. Lindon JC, Nicholson JK, Everett JR. NMR of biofluids. NMR Spec. 1999;38:2-87.
19. Nicholson JK, Foxall PJD. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Biochem. 1995;67:793-811.
20. Holmes E, Foxal PJD, Nicholson JK, et al. Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonancespectra of human urine from normal and pathological states. Anal Biochem. 1994;220:284-296. (Pubitemid 24261170)
21. Andreadou I, Sigala F, Iliodromitis EK, et al. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J Mol Cell Cardiol. 2007;42:549-558. (Pubitemid 46357553)
22. Cai M, Ogawa R. Effects of free radical scavengers methylprednisolone and ulinastatin on acute xanthine and xanthine-oxidase induced lung injury in rats. Circ Shock. 1994;43:1-78.
23. Tanaka M, Fujiwara H, Yamasaki K, et al. Superoxide dismutase and N-mercaptopropionyl glycine attenuate infarct size limitation of ischemic preconditioning in the rabbit. Cardiovasc Res. 1994;28:980-986.
24. Tang X-L, Takano H, Rizvi A, et al. Oxidant species trigger late preconditioningagainst myocardial stunning in conscious rabbits. Am J Physiol. 2002;282:H281-H291. (Pubitemid 34654160)
25. Turan N, Csonska C, Csont T, et al. The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts. Cardiovasc Res. 2006;70:384-390.
26. Morishira M, Hasebe N, Bajinnyam E, et al. Ischemic preconditioning enhances scavenging activity of reactive oxygen species and diminishes transmural difference of infarct size. Am J Physiol Heart Circ Physiol. 2006;290:H577-H583.
27. Ceconi M, Bernocchi P, Boraso A, et al. New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage. Cardiovasc Res. 2000;47:586-594. (Pubitemid 30646080)
28. Fuchs J, Mainka L, Zimmer G. 2-mercaptopropionylglycine and related compounds in treatment of mitochondrial dysfunction and post ischemic myocardial damage. Arzneimittelforschung. 1985;35:1394-1402. (Pubitemid 15230648)
29. Steare SE, Yellon DM. The potential for endogenous myocardial antioxidants to protect the myocardium against ischemia reperfusion injury: Refreshing the parts exogenous antioxidants cannot reach? J Mol Cell Cardiol. 1995;27:65-74.
30. Ziegler DM. Role of reversible oxidation-reduction of enzyme thioldisulfides in metabolic regulation. Annu Rev Biochem. 1985;54:305-329. (Pubitemid 15073649)
31. Mannervick B, Axelsson K. Role of cytoplasmic thioltransferase in cellular regulation by thiol-disulfide interchange. Biochem J. 1980;190: 125-130.
32. Fuchs J, Veit P, Zimmer G. Uncoupler and hypoxia-induced damage in the working rat heart and its treatment. II. Hypoxic reduction of aortic flow and its reversal. Basic Res Cardiol. 1985;80:23-40.
33. Facundo HTF, de Paula JG, Kowaltowski AJ. Mitochondrial ATPsensitive K+ channels are redox-sensitive pathways that control reactiveoxygen species production. Free Radic Biol Med. 2007;42:1039-1048. (Pubitemid 46356894)
34. Stanley WC. Cardiac energetic during ischemia and the rationale for metabolic interventions. Coron Artery Dis. 2001;12:53-57.
35. Robert BJ, Hal KH, James EL, et al. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol. 1978;92:187-214.
36. Khaliulin I, Clarke SJ, Lin H, et al. Temperature preconditioning in isolated rat hearts-a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol. 2007;581:1147-1161. (Pubitemid 46887984)
37. Fuchs J, Zimmer G. 31P-NMR spectroscopic investigations and mitochondrial studies on the cardioprotective efficiency of 2-mercaptopropionylglycine. Biochem Pharmacol. 1986;35:4381-4385. (Pubitemid 17223267)
38. Robinson AM, Wiliamson DH. Physiological roles of ketone bodies as substrate and signals in mammalian tissues. Physiol Rev. 1980;60: 143-187. (Pubitemid 10104513)
39. Zou Z, Sasaguri S, Rajesh KG, et al. dl-3-hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. Am J Physiol Heart Circ Physiol. 2002;283:H1968-H1974. (Pubitemid 35217031)
40. Lockwood TD. Redox pacing of proteome turnover: Influences of glutathione and ketonemia. Arch Biochem Biophys. 2003;417:183-193. (Pubitemid 36993794)
41. Squires JE, Sun J, Caffrey JL, et al. Acetoacetate augments b-adrenergic inotropism of stunned myocardium by an antioxidant mechanism. Am J Physiol Heart Circ Physiol. 2003;284:H1340-H1347. (Pubitemid 36348598)
42. Sun J, Squires JE, Mallet RT. Acetoacetate restores contractile performance and antioxidant potential of H2O2 injured myocardium. J Mol Cell Cardiol. 2001;33A:115.
43. Uppu RM, Pryor WA. Carbon dioxide catalysis of the reaction of peroxynitrite with ethyl acetoacetate: An example of aliphatic nitration with peroxynitrite. Biochem Biophys Res Commun. 1996;229:764-769. (Pubitemid 27035793)